Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico--striatal terminals in vitro.
D000818:Animals; D002118:Calcium / Q000502:physiology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D005971:Glutamates / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*
D005971:Glutamates; D011954:Receptors, Dopamine; D006220:Haloperidol; D011188:Potassium; D002118:Calcium